Literature DB >> 267509

Potential advances in the clinical use of arabinosyl cytosine.

D H Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 267509

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.

Authors:  H Hasle
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.

Authors:  Gudrun Fleischhack; Ulrich Jaehde; Udo Bode
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  High dose Ara-C related leukoencephalopathy.

Authors:  T L Hwang; W K Yung; Y Y Lee; A Borit; W S Fields
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.

Authors:  Naotake Funamizu; Curtis Ray Lacy; Kaori Fujita; Kenei Furukawa; Takeyuki Misawa; Katsuhiko Yanaga; Yoshinobu Manome
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.